Reply to: "Survival Analysis of TP53 Co-Mutations Should be Interpreted More Cautiously". Saleh MM, Scheffler M, Merkelbach-Bruse S, Wolf J, et al. J Thorac Oncol 2022;17:e57-e59.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saleh MM, Scheffler M, Merkelbach-Bruse S, Wolf J, et al. Reply to: "Survival Analysis of TP53 Co-Mutations Should be Interpreted More Cautiously". J Thorac Oncol 2022;17:e57-e59.
PMID: 35623679